South Korean Biotech Licensing Deals Top ₩21 Trillion, but Stock Prices Lag — Recovery Hinges on Market Liquidity — BigGo Finance
South Korean pharmaceutical and biotech companies have surpassed ₩21 trillion (approximately $15.5 billion) in out-licensing contract value this…